These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29597076)

  • 1. Genome engineering for CNS injury and disease.
    Pardieck J; Sakiyama-Elbert S
    Curr Opin Biotechnol; 2018 Aug; 52():89-94. PubMed ID: 29597076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS disease models with human pluripotent stem cells in the CRISPR age.
    Muffat J; Li Y; Jaenisch R
    Curr Opin Cell Biol; 2016 Dec; 43():96-103. PubMed ID: 27768957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
    Nelson CE; Robinson-Hamm JN; Gersbach CA
    Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system.
    Ren X; Holsteens K; Li H; Sun J; Zhang Y; Liu LP; Liu Q; Ni JQ
    Sci China Life Sci; 2017 May; 60(5):476-489. PubMed ID: 28527116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome engineering tools for building cellular models of disease.
    Lin J; Musunuru K
    FEBS J; 2016 Sep; 283(17):3222-31. PubMed ID: 27218233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cells -- a versatile tool for cell replacement and gene therapy in the central nervous system.
    Ourednik V; Ourednik J; Park KI; Snyder EY
    Clin Genet; 1999 Oct; 56(4):267-78. PubMed ID: 10636444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and future editing reagent delivery systems for plant genome editing.
    Ran Y; Liang Z; Gao C
    Sci China Life Sci; 2017 May; 60(5):490-505. PubMed ID: 28527114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome editing for crop improvement: Challenges and opportunities.
    Abdallah NA; Prakash CS; McHughen AG
    GM Crops Food; 2015; 6(4):183-205. PubMed ID: 26930114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To CRISPR and beyond: the evolution of genome editing in stem cells.
    Chen KY; Knoepfler PS
    Regen Med; 2016 Dec; 11(8):801-816. PubMed ID: 27905217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Macromolecule Delivery Tools for Plant Genetic Modification in the Era of Precision Genome Engineering.
    Que Q; Chilton MM; Elumalai S; Zhong H; Dong S; Shi L
    Methods Mol Biol; 2019; 1864():3-18. PubMed ID: 30415325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
    Gaj T; Epstein BE; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for CNS fibroblasts in health, injury and disease.
    Dorrier CE; Jones HE; Pintarić L; Siegenthaler JA; Daneman R
    Nat Rev Neurosci; 2022 Jan; 23(1):23-34. PubMed ID: 34671105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic biology approaches in cancer immunotherapy, genetic network engineering, and genome editing.
    Chakravarti D; Cho JH; Weinberg BH; Wong NM; Wong WW
    Integr Biol (Camb); 2016 Apr; 8(4):504-17. PubMed ID: 27068224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
    Chaterji S; Ahn EH; Kim DH
    Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrus Genetic Engineering for Disease Resistance: Past, Present and Future.
    Sun L; ; Ke F; Nie Z; Wang P; Xu J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.